Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money ...

While there have been reports from drugmakers about possible interruptions with FDA matters due to staff layoffs, one company ...

Analysis found 25% tariff on pharmaceutical imports would hike U.S. drug costs by nearly $51 billion annually, boosting ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Many doctors recommend routine follow-up tests for cancer patients after they’ve completed a course of treatment, with the ...

A closely watched clinical trial testing what could be the world’s first new tuberculosis vaccine in a century has hit its ...

A close look at Chris Klomp's path to the top of Medicare, which pays for the health care of 68 million Americans.

Confounded by a confusing expression or dream from a patient, I might seemingly shift gears and ask myself, 'What if this ...

Device companies already enjoy big profit margins and are finding ways to avoid the impact of President Trump's tariffs.

After months of discussion, Germany’s Merck KGaA said Monday it would buy SpringWorks Therapeutics for $47 a share in cash, a ...

As Congress returns to work, STAT is tracking what health spending will get cut and when RFK Jr. will testify.

While physician-scientists are supported in splitting their time between research and clinical work, nurse-scientists are not ...